Skip to main content
. 2016 Mar 15;7(17):24050–24062. doi: 10.18632/oncotarget.8079

Figure 7.

Figure 7

Phase-contrast images of SKOV-3 and OVCAR-3 cells A. after treating with cRGD or B. after treating with uPA si-RNA.